Factors associated with reattendance to emergency services following COVID-19 hospitalization.
作者信息
Daunt Anna, Perez-Guzman Pablo N, Cafferkey John, Manalan Kavina, Cooke Graham, White Peter J, Hauck Katharina, Mallia Patrick, Nayagam Shevanthi
机构信息
Department of Infectious Disease Epidemiology, MRC Centre for Global Infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics (J-IDEA), School of Public Health, Imperial College London, London, UK.
Division of Digestive Diseases, Department of Metabolism, Digestion, and Reproduction, Faculty of Medicine, Imperial College Healthcare NHS Trust, London, UK.
出版信息
J Med Virol. 2021 Mar;93(3):1250-1252. doi: 10.1002/jmv.26594. Epub 2020 Oct 30.
Abstract
摘要
相似文献
1
Factors associated with reattendance to emergency services following COVID-19 hospitalization.与新冠病毒感染住院后再次前往急诊服务相关的因素。
J Med Virol. 2021 Mar;93(3):1250-1252. doi: 10.1002/jmv.26594. Epub 2020 Oct 30.
2
SARS-CoV-2 Infection, Hospitalization, and Associated Factors Among People Living With HIV in Southeastern China From December 2022 to February 2023: Cross-Sectional Survey.2022 年 12 月至 2023 年 2 月中国东南部 HIV 感染者中 SARS-CoV-2 感染、住院和相关因素的横断面调查。
JMIR Public Health Surveill. 2024 Apr 17;10:e51449. doi: 10.2196/51449.
3
Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages.与非 AY.4.2 德尔塔变异亚系相比，感染 SARS-CoV-2 AY.4.2（VUI-21OCT-01）的 COVID-19 病例的住院和死亡风险。
J Infect Dis. 2022 Sep 13;226(5):808-811. doi: 10.1093/infdis/jiac063.
4
Incidentally Detected SARS-COV-2 Among Hospitalized Patients in Los Angeles County, August to October 2020.2020 年 8 月至 10 月，洛杉矶县住院患者中偶然检出 SARS-COV-2。
J Hosp Med. 2021 Aug;16(8):480-483. doi: 10.12788/jhm.3641.
5
Clinical manifestations and disease severity of SARS-CoV-2 infection among infants in Canada.加拿大婴儿中严重急性呼吸综合征冠状病毒 2 感染的临床表现和疾病严重程度。
PLoS One. 2022 Aug 24;17(8):e0272648. doi: 10.1371/journal.pone.0272648. eCollection 2022.
6
Analysis of Rituximab Use, Time Between Rituximab and SARS-CoV-2 Vaccination, and COVID-19 Hospitalization or Death in Patients With Multiple Sclerosis.分析利妥昔单抗的使用、利妥昔单抗与 SARS-CoV-2 疫苗接种之间的时间间隔以及多发性硬化症患者 COVID-19 住院或死亡的情况。
JAMA Netw Open. 2022 Dec 1;5(12):e2248664. doi: 10.1001/jamanetworkopen.2022.48664.
7
Risk of hospitalization for self-harm among adults hospitalized with SARS-CoV-2 in France: A nationwide retrospective cohort study.法国因 SARS-CoV-2 住院的成年人因自残而住院的风险：一项全国性回顾性队列研究。
Psychiatry Res. 2023 Jun;324:115214. doi: 10.1016/j.psychres.2023.115214. Epub 2023 Apr 15.
8
Risks of SARS-CoV-2 JN.1 Infection and COVID-19-Associated Emergency Department Visits/Hospitalizations Following Updated Boosters and Prior Infection: A Population-Based Cohort Study.更新加强针接种和既往感染后，感染 SARS-CoV-2 JN.1 株的风险与 COVID-19 相关的急诊科就诊/住院：一项基于人群的队列研究。
Clin Infect Dis. 2024 Nov 22;79(5):1190-1196. doi: 10.1093/cid/ciae339.
9
SARS-CoV-2 Antibodies and Associated Factors at Different Hospitalization Time Points in 192 COVID-19 Cases.192 例 COVID-19 患者不同住院时间点的 SARS-CoV-2 抗体及相关因素。
J Appl Lab Med. 2021 Sep 1;6(5):1133-1142. doi: 10.1093/jalm/jfab003.
10
Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19-Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection - United States, June 2021-February 2022.COVID-19 mRNA 疫苗接种在预防既往 SARS-CoV-2 感染成年人 COVID-19 相关住院方面的有效性-美国，2021 年 6 月-2022 年 2 月。
MMWR Morb Mortal Wkly Rep. 2022 Apr 15;71(15):549-555. doi: 10.15585/mmwr.mm7115e2.
引用本文的文献
1
Reattendances in primary care and their association with patient safety events: A cohort study in Spain.基层医疗中的再次就诊情况及其与患者安全事件的关联：西班牙的一项队列研究。
Aten Primaria. 2025 May 30;57(12):103298. doi: 10.1016/j.aprim.2025.103298.
2
An emerging entity after pandemic: Post-coronavirus disease 2019 syndrome and associated medical complications.疫情后出现的一种新情况：2019冠状病毒病后综合征及相关医学并发症。
SAGE Open Med. 2021 Jun 10;9:20503121211023631. doi: 10.1177/20503121211023631. eCollection 2021.
本文引用的文献
1
Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization for COVID-19.COVID-19 出院后返院患者的特征。
J Gen Intern Med. 2020 Oct;35(10):2838-2844. doi: 10.1007/s11606-020-06120-6. Epub 2020 Aug 19.
2
Analysis of Risk Factors on Readmission Cases of COVID-19 in the Republic of Korea: Using Nationwide Health Claims Data.分析韩国新冠肺炎再次入院病例的危险因素：利用全国健康保险索赔数据。
Int J Environ Res Public Health. 2020 Aug 12;17(16):5844. doi: 10.3390/ijerph17165844.
3
COVID-19: Outcomes of patients with confirmed COVID-19 re-admitted to hospital.新冠病毒病（COVID-19）：确诊感染新冠病毒病后再次入院患者的治疗结果
J Infect. 2020 Sep;81(3):e18-e19. doi: 10.1016/j.jinf.2020.07.007. Epub 2020 Jul 8.
4
Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease.英国早期药物获取计划中关于瑞德西韦用于新冠病毒疾病患者的标准的有效性。
J Infect. 2020 Oct;81(4):647-679. doi: 10.1016/j.jinf.2020.06.049. Epub 2020 Jun 21.
5
Clinical characteristics of rehospitalized patients with COVID-19 in China.中国 COVID-19 再住院患者的临床特征。
J Med Virol. 2020 Oct;92(10):2146-2151. doi: 10.1002/jmv.26002. Epub 2020 Jun 9.
6
COVID-19 and clinical mimics. Correct diagnosis is the key to appropriate therapy.新型冠状病毒肺炎及临床疑似病例。正确诊断是恰当治疗的关键。
Monaldi Arch Chest Dis. 2020 May 6;90(2). doi: 10.4081/monaldi.2020.1327.
7
A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data.将埃利克斯豪泽共病测量法修改为一种使用行政数据的医院死亡点数系统。
Med Care. 2009 Jun;47(6):626-33. doi: 10.1097/MLR.0b013e31819432e5.
Zotero 插件